Cohen Fred E 4
4 · Intellia Therapeutics, Inc. · Filed Jan 7, 2026
Insider Transaction Report
Form 4
Cohen Fred E
Director
Transactions
- Purchase
Common Stock
2026-01-05$9.35/sh+150,000$1,402,500→ 207,453 total
Footnotes (2)
- [F1]Reflects an open market purchase of shares of the Issuer's common stock by the Reporting Person in accordance with the Issuer's trading policies.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.13 to $9.68, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares purchased by the reporting person on January 5, 2026 at each separate price.